HopeStage
Back to all studies
WithdrawnNCT02432066

Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions

Medication studyAges 25–60Addiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 25 years to 60 years.

Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: September 29, 2018
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University of Florida
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Not clearly listed
Age range
From 25 Years to 60 Years
Official registry ID
NCT02432066
Official title
Show the full official title

Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions

Recruitment & locations

Withdrawn

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Florida, a university.

Does this study involve medication?

Yes. The study involves medication, including GTS-21 and Placebo.

Who can participate?

Listed age limits: 25 years to 60 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies